Drugs (Price Control) Order, Supreme Court Upholds Rs 4.6 Crore Recovery Against Sun Pharma For Overpricing Medicine

In a significant judgment, the Supreme Court of India has addressed the issue of pharmaceutical pricing and regulatory compliance under the Drugs (Price Control) Order, 1995 (DPCO). The case in question, Civil Appeal No. 7209 of 2019, involved M/s. Sun Pharmaceutical Industries Ltd. as the appellant and the Union of India along with other respondents. Case Summary The dispute arose from the demands made by the National Pharmaceutical Pricing Authority…